Related Experiment Video
Updated: Jun 26, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma
K J Bulpitt1, P J Clements, P A Lachenbruch
1Cooperative Systematic Studies of the Rheumatic Diseases Program, University of Utah, Salt Lake City.
Objective:
To characterize the course of early scleroderma and to delineate prognostic factors present within 1 year of disease onset that might identify patients at high risk.
Design:
Inception cohort study.
Setting:
Ten university-based rheumatology clinics participating in the Cooperative Systematic Studies of Rheumatic Diseases Program.
Patients:
Forty-eight patients who had had scleroderma for less than 1 year.
Measurements:
Fifteen patients with early scleroderma who died were compared with those still living during the initial study period (1982 to 1992). Kaplan-Meier survival estimation and Cox proportional hazards analysis were used to analyze baseline variables for their ability to predict survival duration.
Results:
Eight of 15 deaths were due to cardiac or pulmonary system failure. The estimated 5-year survival rate was 68%. Baseline factors that were the most predictive of a poor outcome included the presence of abnormal cardiopulmonary signs and abnormal urine sediment (pyuria, hematuria).
Conclusion:
Evidence of early cardiopulmonary disease, renal disease, inflammation, or immune activation may identify a subset of patients with scleroderma who will experience rapidly progressive disease and early death.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Healing II: Complications

